MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates

Kidney International

Volumn 68, Issue 2, 2005, Pages 611-622

  Pittock, Siobhan T ^a   Norby, Suzanne M ^a   Grande, Joseph P ^a   Croatt, Anthony J ^a   Bren, Gary D ^a   Badley, Andrew D ^a   Caplice, Noel M ^a   Griffin, Matthew D ^a   Nath, Karl A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytoprotection; Heme oxygenase 1; Ischemia; Kidney; Monocyte chemoattractant protein 1

Indexed keywords

CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; HEME OXYGENASE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; CCL2 PROTEIN, MOUSE; HEME OXYGENASE; HEMOGLOBIN; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GLOMERULUS; INTERSTITIAL NEPHRITIS; ISCHEMIA; KIDNEY; KIDNEY INJURY; KNOCKOUT MOUSE; LEUKOCYTE; MALE; MORTALITY; MOUSE; NEPHROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE; AGE; ANIMAL; GENETICS; KIDNEY DISEASE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; STRESS; SURVIVAL RATE;

AGE FACTORS; ANIMALS; CHEMOKINE CCL2; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMOGLOBINS; ISCHEMIA; KIDNEY DISEASES; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; STRESS; SURVIVAL RATE; UP-REGULATION;

EID: 26944438020     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00439.x     Document Type: Article

References (47)

1. AGARWAL A, NICK HS: Renal response to tissue injury: Lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol 11:965-973, 2000
2. KANWAR YS: Heme oxygenase-1 in renal injury: Conclusions of studies in humans and animal models. Kidney Int 59:378-379, 2001
3. KANAKIRIYA S, NATH KA: Heme oxygenase and acute renal injury, in Acute Renal Failure: A Companion to Brenner and Rector's The Kidney, edited by Molitoris B, Finn WF, Philadelphia, W.B. Saunders, 2001, pp 78-88
4. SIKORSKI EM, HOCK T, HILL-KAPTURCZAK N, AGARWAL A: The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 286:F425-F441, 2004
5. NATH KA, BALLA G, VERCELLOTTI GM, et al: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90:267-270, 1992
6. BARANANO DE, WOLOSKER H, BAE BI, et al: A mammalian iron ATPase induced by iron. J Biol Chem 275:15166-15173, 2000
7. HAYASHI S, TAKAMIYA R, YAMAGUCHI T, et al: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: Role of bilirubin generated by the enzyme. Circ Res 85:663-671, 1999
8. LEUNG N, CROATT AJ, HAGGARD JJ, et al: Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 60:1047-1057, 2001
9. OTTERBEIN LE, BACH FH, ALAM J, et al: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428, 2000
10. OTTERBEIN LE, ZUCKERBRAUN BS, HAGA M, et al: Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9:183-190, 2003
11. INGUAGGIATO P, GONZALEZ-MICHACA L, CROATT AJ, et al: Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 60:2181-2191, 2001
12. DUCKERS HJ, BOEHM M, TRUE AL, et al: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7:693-698, 2001
13. NATH KA, VERCELLOTTI GM, GRANDE JP, et al: Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kidney Int 59:106-117, 2001
14. CHARO IF, PETERS W: Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization. Microcirculation 10:259-264, 2003
15. DALY C, ROLLINS BJ: Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies. Microcirculation 10:247-257, 2003
16. TESCH GH, MAIFERT S, SCHWARTING A, et al: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas (lpr) mice. J Exp Med 190:1813-1824, 1999
17. KIM HL, LEE DS, YANG SH, et al: The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 40:1146-1152, 2002
18. VIEDT C, DECHEND R, FEI J, et al: MCP-1 induces inflammatory activation of human tubular epithelial cells: Involvement of the transcription factors, nuclear factor-kappaB and activating protein-1. J Am Soc Nephrol 13:1534-1547, 2002
19. BANBA N, NAKAMURA T, MATSUMURA M, et al: Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58:684-690, 2000
20. AGARWAL R: Proinflammatory effects of oxidative stress in chronic kidney disease: Role of additional angiotensin II blockade. Am J Physiol Renal Physiol 284:F863-F869, 2003
21. SUNG FL, ZHU TY, AU-YEUNG KK, et al: Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-κB. Kidney Int 62:1160-1170, 2002
22. CAO CC, DING XQ, OU ZL, et al: In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65:834-845, 2004
23. FURUICHI K, WADA T, IWATA Y, et al: CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14:2503-2515, 2003
24. FURUICHI K, WADA T, IWATA Y, et al: Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 14:1066-1071, 2003
25. NAKAMURA M, KYO S, KANAYA T, et al: hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin. Cancer Gene Ther 11:1-7, 2004
26. KANAKIRIYA SK, CROATT AJ, HAGGARD JJ, et al: Heme: A novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Am J Physiol Renal Physiol 284:F546-F554, 2003
27. NATH KA, HAGGARD JJ, CROATT AJ, et al: The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156:1527-1535, 2000
28. POSS KD, TONEGAWA S: Heme oxygenase-1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94:10919-10924, 1997
29. ORLANDI M, BARTOLINI G, CHIRICOLO M, et al: Prostaglandin and thromboxane biosynthesis in isolated platelet-free human monocytes. I. A modified procedure for the characterization of the prostaglandin spectrum produced by resting and activated monocytes. Prostaglandins Leukot Med 18:205-216, 1985
30. RABB H, RAMIREZ G, SABA SR, et al: Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol 271:F408-F413, 1996
31. ZAGER RA, JOHNSON A, HANSON S, DELA ROSA V: Altered cholesterol localization and caveolin expression during the evolution of acute renal failure. Kidney Int 61:1674-1683, 2002
32. NATH KA, CROATT AJ, HAGGARD JJ, GRANDE JP: Renal response to repetitive exposure to heme proteins: Chronic injury induced by an acute insult. Kidney Int 57:2423-2433, 2000
33. NIGRO JM, TAKAHASHI MA, GINZINGER DG, et al: Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 158:1253-1262, 2001
34. SHIMIZU H, TAKAHASHI T, SUZUKI T, et al: Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 28:809-817, 2000
35. KAIZU T, TAMAKI T, TANAKA M, et al: Preconditioning with tinprotoporphyrin IX attenuates ischemia/reperfusion injury in the rat kidney. Kidney Int 63:1393-1403, 2003
36. AGARWAL A, BALLA J, ALAM J, et al: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298-1307, 1995
37. GRUNDEMAR L, NY L: Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18:193-195, 1997
38. KRAMER AA, POSTLER G, SALHAB KF, et al: Renal ischemia/ reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 55:2362-2367, 1999
39. KELLY KJ: Distant effects of experimental renal ischemia/ reperfusion injury. J Am Soc Nephrol 14:1549-1558, 2003
40. SIMMONS EM, HIMMELFARB J, SEZER MT, et al: PICARD Study Group. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65:1357-1365, 2004
41. HATTORI Y, MATSUMURA M, KASAI K: Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58:186-195, 2003
42. LOBO SM, LOBO FR, BOTA DP, et al: C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123:2043-2049, 2003
43. WOLF G, JOCKS T, ZAHNER G, et al: Existence of a regulatory loop between MCP-1 and TGF-beta in glomerular immune injury. Am J Physiol Renal Physiol 283:F1075-F1084, 2002
44. KAFTURCZAK MH, WASSERFALL C, BRUSKO T, et al: Heme oxygenase-1 modulates early inflammatory responses: Evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165:1045-1053, 2004
45. OHTA K, YACHIE A, FUJIMOTO K, et al: Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis 35:863-870, 2000
46. YACHIE A, NIIDA Y, WADA T, et al: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103:129-135, 1999
47. EXNER M, MINAR E, WAGNER O, SCHILLINGER M: The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37:1097-1104, 2004